...
首页> 外文期刊>Pharmaceutical Chemistry Journal >Hampered Binding to Blood Serum Proteins and the Biological Activity of Antimicrobial Peptide Containing N 3 -(4-Methoxyfumaroyl)-L-2,3-Diaminopropanoic Acid Immobilized on Magnetic Nanoparticles
【24h】

Hampered Binding to Blood Serum Proteins and the Biological Activity of Antimicrobial Peptide Containing N 3 -(4-Methoxyfumaroyl)-L-2,3-Diaminopropanoic Acid Immobilized on Magnetic Nanoparticles

机译:被阻碍与血清蛋白质的结合和含有N 3 - (4-甲氧基)-L-2,3-二氨基丙酮的抗微生物肽的生物活性固定在磁性纳米粒子上

获取原文
获取原文并翻译 | 示例

摘要

Peptides containing N 3 -(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid (FMDP) are known as antifungal and antibacterial agents. However, FMDP peptides bind to the blood serum proteins in an irreversible way thereby losing their biological activity. In the present work, one of the most potent FMDP peptides, LysNvaFMDP, was immobilized on iron-oxide(II/III) magnetic nanoparticles (MNPs) in order to obtain a potentially more resistant form of this compound capable of binding to proteins. The obtained nanostructures were characterised using FT-IR and DLS techniques. Then, the degree of binding of the immobilized FMDP agent to albumin from bovine pancreas and to the proteins from human blood serum was tested using UV-VIS spectrophotometric method in comparison to the unbound form of this peptide. Microbial growth inhibition tests were also carried out. The form of LysNvaFMDP immobilized on MNPs turned out to have lower affinity to the proteins in comparison to the unbound form and, as a result, it showed a higher antimicrobial activity against Lactobacillus acidophilus ATCC 4356 strain. The immobilized form of FMDP agent is significantly protected from binding to albumin and other blood serum proteins and thus retains its antimicrobial activity. It is possible that such a form of this agent will reach clinics.
机译:含有N 3 - (4-甲氧基甲酰基)-L-2,3-二氨基丙酸(FMDP)的肽称为抗真菌剂和抗菌剂。然而,FMDP肽以不可逆的方式与血清血清蛋白结合,从而损失其生物活性。在本作本作中,最有效的FMDP肽LysnvafMDP在氧化铁(II / III)磁性纳米颗粒(MNP)上固定,以获得能够与蛋白质结合的该化合物的潜在更耐药形式。使用FT-IR和DLS技术表征获得的纳米结构。然后,使用UV-Vis分光光度法测试将固定的FMDP试剂与来自人血清中的蛋白质的蛋白质的结合程度与该肽的未结合形式进行测试。还进行了微生物生长抑制试验。与未结合形式相比,固定在MNP上的LysnvafMDP的形式对蛋白质具有较低的亲和力,结果表明,它显示出对乳杆菌酸痛4356菌株的更高抗微生物活性。固定化的FMDP剂形式被显着保护与白蛋白和其他血清蛋白结合,因此保留其抗微生物活性。这种代理的这种形式可能会达到诊所。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号